Correction: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5
- PMID: 32821347
- PMCID: PMC7415401
- DOI: 10.18632/oncotarget.27690
Correction: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5
Abstract
[This corrects the article DOI: 10.18632/oncotarget.16055.].
Copyright: © 2020 Al-Jameel et al.
Erratum for
-
Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5.Oncotarget. 2017 May 9;8(19):31041-31056. doi: 10.18632/oncotarget.16055. Oncotarget. 2017. PMID: 28415688 Free PMC article.
References
-
- Janik P, Briand P, Hartmann NR. The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors. Cancer Res. 1975; 35:3698–704. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
